Clinical Trial Update: Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue [Phase 3]

View source ↗

Summary

Phase 3 trial of 4-Hydroxytamoxifen (4-OHT) gel in women aimed at reducing dense breast tissue; study terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dense Breast Tissue
• Mammographic Breast Density

Drugs mentioned

• 4-Hydroxytamoxifen Gel (4-hydroxytamoxifen gel)

Snippet

Sponsor: BHR Pharma, LLC | Conditions: Mammographic Breast Density | Phase 3 | Status: TERMINATED | Results posted: 2021-11-17